Logo
Logo

About Ferric Carboxymaltose API

Product
  • Therapeutic CategoryNephrology

  • CAS Number

    9007-72-1

  • API Technology

    Iron Product

  • Dose Form

    Injectable

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, China DMF, Malaysia DMF, Saudi Arabia

Mechanism of Action

Ferric carboxymaltose is a colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron.

Indication

Injectafer is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients:

  • Who have intolerance to oral iron or have had unsatisfactory response to oral iron;
  • Who have non-dialysis dependent chronic kidney disease.

Related APIs

Ferric Carboxymaltose

Nephrology

arrow

Iron Sucrose (Available For Selected Markets)

Nephrology

arrow

Roxadustat Monohydrate - Form A

Nephrology

arrow

Voclosporin

Nephrology

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.